Origin WW

Princeton, United States Founded: 2010 • Age: 16 yrs
Drug delivery platform for skin and soft-tissue infections is developed.
Annual revenue - Latest available
Total funding $1.9M 3 rounds
Employees - Tracked headcount
Investors - Known backers
Products 1 Services tracked
Competitors 10 Brand Intelligence

About Origin WW

Origin WW is a company based in Princeton (United States) founded in 2010. Origin WW has raised $1.88 million across 3 funding rounds. Origin WW offers products and services including IonoJet™. Origin WW operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.

  • Headquarter Princeton, United States
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Origin Life Sciences, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $1.88 M (USD)

    in 3 rounds

  • Latest Funding Round
    $51 K (USD), Seed

    Oct 17, 2023

  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Origin WW

Origin WW offers a comprehensive portfolio of products and services, including IonoJet™.

Product name locked
Category locked
Primary

Generates nitric oxide for wound healing and infection treatment applications.

People of Origin WW

Headcount 1-10
Employee Profiles 9
Board Members and Advisors 1
Employee Profiles
People
Leigh Gourmand
VP, Finance & Controller
People
Kathleen Bannon
VP, Marketing, US Commercial Strategy
People
David Dantzker
Deputy Chairman and Chief Medical Officer
People
Michael Preston
Chairman & CEO

Unlock access to complete

Board Members and Advisors
people
Jerome Boda Korten
Director

Unlock access to complete

Funding Insights of Origin WW

Origin WW has successfully raised a total of $1.88M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $51 thousand completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investments & Acquisitions by Origin WW

Investments
Premium access

Investment portfolio details for Origin WW

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Origin WW

Premium access

Detailed financials for Origin WW

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Origin Ww Comparisons

Origin WW Primary company
Description
Drug delivery platform for skin and soft-tissue infections i...
Location
Princeton, United States
Founded Year
2010
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Origin WW

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Origin WW

Origin WW operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Antibody-siRNA complexes are developed for cancer treatment.
Locked Locked Locked
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
Locked Locked Locked
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
Locked Locked Locked
Developing novel drugs based on a proteome-wide ligand and target discovery platform
Locked Locked Locked
RNA-editing technologies are provided for precision medicine applications.
Locked Locked Locked
Dental implants and regenerative dentistry products are developed.
Premium access

Detailed competitors of Origin WW

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Origin Ww

Premium access

Complete news archive for Origin WW

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Origin WW

Origin WW was founded in 2010 and raised its 1st funding round 7 years after it was founded.

Origin WW is headquartered in Princeton, United States. It is registered at Princeton, New Jersey, United States.

Origin WW is a funded company, having raised a total of $1.88M across 3 funding rounds to date.

Origin was founded in 2010 and is headquartered in Princeton, United States. The company operates in the biotechnology sector, focusing on a patented drug delivery platform called IonoJet. This technology facilitates targeted nitric oxide delivery from room air at the treatment site. Products developed include IonoStim for wound healing, Ionoderma for onychomycosis, Ionosite for arthritis and tendinitis, and Ionodent for periodontitis and implantitis, addressing various skin and soft-tissue conditions.

Origin WW's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.

Origin WW offers IonoJet™.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available